Understanding blood cell development in patients with a specific genetic mutation
Hematopoiesis in germline RUNX1mutation carriers: impact of inflammation and the bone marrow niche
This study is looking at how inflammation and the environment in your bone marrow affect blood cell development in people with a specific genetic change that raises the risk of leukemia, with the goal of finding ways to catch and prevent leukemia early and improve care for those at risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-10842356 on NIH RePORTER |
What this research studies
This research investigates how inflammation and the bone marrow environment affect blood cell development in individuals with germline RUNX1 mutations, which are linked to an increased risk of leukemia. The study aims to identify the molecular changes that occur before leukemia develops, providing insights into early detection and prevention strategies. By examining the unique challenges faced by these patients, the research seeks to improve monitoring and treatment options for those at risk. Participants may undergo various assessments to understand their hematopoietic health and the factors influencing their condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with germline RUNX1 mutations, particularly those with a family history of leukemia.
Not a fit: Patients without germline RUNX1 mutations or those not at risk for hematopoietic malignancies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved early detection and prevention strategies for leukemia in patients with RUNX1 mutations.
How similar studies have performed: Previous research has shown promise in understanding genetic mutations related to leukemia, making this approach both relevant and potentially impactful.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Agarwal, Anupriya — Oregon Health & Science University
- Study coordinator: Agarwal, Anupriya
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.